Psychedelics Synthetic ibogaine: a game changer for mental health treatment Scientists at UC Davis are making a short supply of the African iboga shrub a less significant problem Rowan DunneFebruary 13, 2025
News Delix Therapeutics to start clinical trial on novel psychoplastogen drug DLX-001 is a non-hallucinogenic compound intended to treat various mental health conditions Rowan DunneMay 9, 2023